WELLS FARGO & COMPANY/MN - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40,833
-66.5%
5,735
-52.1%
0.00%
Q2 2023$121,964
+11798.9%
11,969
+10492.0%
0.00%
Q1 2023$1,025
+120.0%
113
+73.8%
0.00%
Q4 2022$46665
+1.6%
0.00%
Q3 2022$064
-3.0%
0.00%
Q2 2022$066
+8.2%
0.00%
Q1 2022$061
+1.7%
0.00%
Q4 2021$0600.0%0.00%
Q3 2021$0600.0%0.00%
Q2 2021$0
-100.0%
60
-97.3%
0.00%
Q1 2021$15,000
-85.7%
2,196
-89.0%
0.00%
Q4 2020$105,000
-13.2%
19,980
+23.0%
0.00%
Q3 2020$121,000
+12.0%
16,242
+11.3%
0.00%
Q2 2020$108,00014,597
+69409.5%
0.00%
Q1 2020$0
-100.0%
21
-89.5%
0.00%
Q4 2019$1,0000.0%200
-51.3%
0.00%
Q2 2019$1,000
-92.3%
411
-90.2%
0.00%
Q1 2019$13,000
-18.8%
4,190
+0.1%
0.00%
Q4 2018$16,000
-36.0%
4,185
-0.6%
0.00%
Q3 2018$25,000
-76.9%
4,210
-77.9%
0.00%
Q2 2018$108,000
+103.8%
19,082
+347.5%
0.00%
Q1 2018$53,000
+2550.0%
4,264
+2032.0%
0.00%
Q4 2017$2,0002000.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,561,474$17,166,0004.25%
AIGH Capital Management LLC 1,346,724$6,491,0001.71%
Worth Venture Partners, LLC 335,985$1,784,0001.05%
Ikarian Capital, LLC 884,008$4,261,0000.78%
Orbimed Advisors 4,797,148$23,122,0000.42%
ARMISTICE CAPITAL, LLC 2,700,000$13,014,0000.23%
Sandy Cove Advisors, LLC 10,592$51,0000.05%
Belvedere Trading LLC 239,219$1,270,0000.04%
IPG Investment Advisors LLC 14,300$69,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,200$637,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders